Form 4 Filing by AbCellera Biologics Inc.

This filing details a Form 4 filed by AbCellera Biologics Inc. on July 6, 2026. The report concerns transactions by Sandor Victor, who holds a director position. On July 1, 2026, Victor was granted 152,207 share options to purchase common shares at a price of $7.85 per share. These options vest in three equal annual installments starting July 1, 2027, contingent upon continuous service to the issuer. The options expire on July 1, 2036. Following this transaction, Victor holds 152,207 shares directly. The filing was made by an attorney-in-fact.